The "Global Infusion Pump Market - Industry Trends, Opportunities and Forecasts to 2023" report has been added to ResearchAndMarkets.com's offering.

Global Infusion Pump Market is expected to witness a CAGR of 5.54% over the forecast period to grow to US$9.763 billion by 2023, growing from US$7.457 billion in 2018.

The infusion pump is a medical device that is used to deliver fluids into a patient's body to infuse nutrients or medications like insulin, other hormones, antibiotics, and pain relievers. Infusion pumps may be stationary or ambulatory that are designed to be to portable or wearable. Different types of infusion pumps like enteral pump, patient-controlled analgesia (PCA) pump and insulin pump are used for specialized purposes.

Depending on the mechanism used they can be classified into syringe pump, elastomeric pump, peristaltic pump, multi-channel pump and smart pump. Geographically North America is the largest market for infusion pumps, followed by Europe, Asia-Pacific, and Latin America. Rising prevalence of chronic diseases, increasing healthcare expenditure and improving healthcare infrastructure are major growth drivers for the market.

Segmentation

By Type

  • Insulin Pump
  • PCA Pump
  • Enteral Pump

By Mechanism

  • Syringe Pump
  • Elastomeric pump
  • Peristaltic pump
  • Multi-channel pump
  • Smart Pump

By Application

  • Chemotherapy
  • Gastroenterology
  • Diabetes
  • Pain management
  • Haematology
  • Others

By Geography

  • Americas
  • North America
  • South America
  • Europe Middle East and Africa
  • Europe
  • Middle East and Africa
  • Asia Pacific

Companies Mentioned

  • Baxter International, Inc.
  • B. Braun Melsungen
  • Medtronic, Inc.
  • Roche Holdings Ltd.
  • Johnson & Johnson
  • Pfizer Inc.
  • Novartis
  • Omnipod (Insulet Corp.)

For more information about this report visit https://www.researchandmarkets.com/research/mnsnnz/global_7_45?w=4